New Guidelines Expand <em>BRCA</em> Screening
New Guidelines Expand BRCA Screening
US Preventive Services Task Force recommends genetic testing for mutations in the cancer-related genes for more—but not all—women.
New Guidelines Expand BRCA Screening
New Guidelines Expand BRCA Screening

US Preventive Services Task Force recommends genetic testing for mutations in the cancer-related genes for more—but not all—women.

US Preventive Services Task Force recommends genetic testing for mutations in the cancer-related genes for more—but not all—women.

BRCA2
MyHeritage Launches Health-Related Genetic Test, Ignites Debate
MyHeritage Launches Health-Related Genetic Test, Ignites Debate
Catherine Offord | Jul 9, 2019
Its screen for selected variants of some disease-linked genes gives customers an incomplete picture of their risk—do they know?
Master Decoder: A Profile of K&aacute;ri Stef&aacute;nsson
Master Decoder: A Profile of Kári Stefánsson
Anna Azvolinsky | Mar 1, 2019
A neurologist by training, Stefánsson founded Iceland-based deCODE Genetics to explore what the human genome can tell us about disease and our species’ evolution.
PARP Inhibitors Are Improving the Outlook of Hard-to-Treat Cancers
PARP Inhibitors Are Improving the Outlook of Hard-to-Treat Cancers
Vicki Brower | Apr 1, 2018
With three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.
First Direct-to-Consumer BRCA Test Authorized by FDA
First Direct-to-Consumer BRCA Test Authorized by FDA
Kerry Grens | Mar 6, 2018
The agency gave personal genomics company 23andMe the green light to screen samples for breast cancer–related genetic mutations.
Genetic Risk Factors for Breast Cancer Identified
Genetic Risk Factors for Breast Cancer Identified
Ashley P. Taylor | Oct 23, 2017
Researchers identify 72 novel genetic variants associated with breast cancer risk.
Q&A: Sequencing Newborns
Q&A: Sequencing Newborns
Tracy Vence | Oct 21, 2016
Members of the BabySeq Project discuss trial enrollment, preliminary findings.
BRCA Breakthroughs?
BRCA Breakthroughs?
Jenny Rood | Apr 21, 2015
Color Genomics announces a new, lower-cost BRCA mutation test, while Inserm and Quest Diagnostics reveal plans to pool patient data to investigate rare mutations.
<em>BRCA</em> Mutations Mapped
BRCA Mutations Mapped
Tracy Vence | Apr 7, 2015
In a large study, researchers find evidence to suggest that the type and location of a woman’s BRCA1/2 mutations may affect her cancer risk.
Yet Another Lawsuit over Genetic Tests
Yet Another Lawsuit over Genetic Tests
Tracy Vence | Jun 17, 2014
Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing another competitor for patent infringement.
Speaking of Science
Speaking of Science
The Scientist Staff | Aug 1, 2013
August 2013's selection of notable quotes
Another Lawsuit over Genetic Tests
Another Lawsuit over Genetic Tests
Kate Yandell | Jul 11, 2013
Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing two competitors for patent infringement.
Gene Patents Decision: Everybody Wins
Gene Patents Decision: Everybody Wins
Jeffrey M. Perkel | Jun 18, 2013
Last week’s Supreme Court decision to invalidate patents on human genes was a win for patients, independent researchers, and even the wider biotech industry.
Supreme Court Nixes Patenting Human Genes
Supreme Court Nixes Patenting Human Genes
Dan Cossins | Jun 13, 2013
The Justices have decided that isolated sequences of human DNA are not eligible for patent protection, but rules that artificial sequences can be patented.
 
Why Women’s Eggs Don’t Last
Why Women’s Eggs Don’t Last
Kate Yandell | Feb 13, 2013
As reproductive tissues age, DNA repair mechanisms become less efficient, causing genomic damage to accumulate.
Should Human Genes be Patented?
Should Human Genes be Patented?
Edyta Zielinska | Dec 3, 2012
The Supreme Court agrees to hear a case deciding if two cancer genes should continue to be protected by patent.
Court Rules Gene Patents Valid
Cristina Luiggi | Aug 17, 2012
Myriad Genetics can hold patents on the BRAC1 and BRAC2 oncogenes, but not on tests comparing DNA sequences.
Gene Patents Back in Court
Cristina Luiggi | Jun 19, 2012
A public interest legal group has renewed the fight against DNA patenting.
A Cancer-Heart Disease Link
Cristina Luiggi | Dec 22, 2011
Mutations known to increase the risk of developing ovarian and breast cancer may also make carriers susceptible to heart failure.
Mom’s Versus Dad’s BRCA
Cristina Luiggi | Dec 13, 2011
The age at which BRCA carriers are diagnosed with breast cancer may depend on which parent contributed the mutation.